FTT 0.00% 0.5¢ factor therapeutics limited

for what purpose?, page-24

  1. 90 Posts.
    lightbulb Created with Sketch. 26
    I too look forward to the release of optimistic P2 results, and the prompt and almost automatic approval from EMA. However, I am just a little concerned by the fact that our current SP is so low that a TO offer, or even partnership negotiation, is going to be based on an abnormally low starting point which would result in limited returns for long term share holders. Also from a low SP, any CR will result in significant dilution for old timers. But as we all know, we will only get exactly what we get and nothing more. 


    So I will hang-in-there and be thankful for what ever comes my way. It will be far superior to that which we were looking at under the previous executive group.


    Roll on results announcement!
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.